We transform Australia & New Zealand's most exciting biomedical research discoveries into new medical products that improve patient outcomes and save lives.

Brandon BioCatalyst is the largest life science investment fund in Australia and New Zealand. We are a unique collaboration between major Australian superannuation funds, CSL, the Australian and New Zealand governments, Australian state governments and more than 50 leading medical research institutes and research hospitals.

Learn more about who we are
CUREator is an Australian national biotechnology incubator supporting the development of pre-clinical and clinical stage medical innovation.

Portfolio

We’re immensely proud of our portfolio. Partnering with talented scientists, clinicians and entrepreneurs, we have supported more than 50 companies to date.

Q-Sera
Q-Sera

A proprietary blood collection tube rapidly providing high quality serum for analysis from all bloods including anti-coagulated

View Project
Ankere Therapeutics
Ankere Therapeutics

Developing novel therapeutics for inflammatory diseases

View Project
Amaroq Therapeutics
Amaroq Therapeutics

Targeting long non-coding RNAs for next generation cancer therapies

View Project
Currus Biologics
Currus Biologics

Developing the next generation of CAR-T cell therapies to treat solid cancers

View Project
Allay Therapeutics
Allay Therapeutics

Combining non-opioid analgesics and biopolymers to deliver weeks of localised pain management

View Project
Myricx Pharma
Myricx Pharma

Unlocking the potential of N-myristoyltransferase (NMT) to develop precision medicines for a range of diseases including cancer and viral infections

View Project
Glyscend
Glyscend

Glyscend is developing novel non-absorbable polymers that are orally-delivered for the treatment of Type 2 Diabetes.

View Project
George Medicines
George Medicines

George Medicines is an innovative late-stage drug development company focused on the large, expanding and underserved market for the management of non-communicable diseases (NCDs)

View Project
See all

Members

Brandon BioCatalyst brings together more than 50 leading medical research institutes across Australia and New Zealand.

Institute
Institute for Molecular Bioscience

IMB is a global leader in multidisciplinary life sciences research, bringing together 500 researchers from across the globe for disease discovery, application and sustainable futures. Formed in 2000 as an initiative of The University of Queensland, State and Federal Governments and private philanthropy, IMB is one of the largest life sciences institutes in the Asia-Pacific region. It has capitalised on one of the greatest periods of discovery in history – the genetic and molecular basis of life and its diversity.

View
Institute
Callaghan Innovation

Callaghan Innovation is the New Zealand government’s innovation agency, helping businesses succeed through technology. We act as a gateway to innovation in New Zealand by connecting the rest of the world to Kiwi companies, research institutes, incubators, universities and commercialisation offices.

View
Institute
ithree institute

The ithree institute brings together a team of scientists with diverse skill sets who collectively address key challenges in the understanding and control of infectious diseases in humans and animals. Our senior scientists have recently refined the key research themes under which they will work together to increase their impact in the antibiotic resistance, food safety and infectious disease space.

View

Membership

Brandon BioCatalyst is innovation in action: We provide a path for taking medical science from conception into the real world.

Our Venture capital model is unique. We don’t simply provide investment, we partner with entrepreneurs to create businesses, run companies and everything necessary to ensure our investments succeed.

Learn more